Increased serum levels of IL-6 have been associated with high risk to develop HCC in patients with chronic hepatitis B and C; accordingly, high serum IL-6 has been frequently observed in patients with HCC and it was associated with a poor prognosis [53–55]. This evidence concerns the gene IL6 and chronic hepatitis B virus infection.